UGT1A1 GenotypingTest Code UGT1A1 Test Synonyms Irinotecan toxicity Associations Metastatic colorectal cancer Methodology Invader® Third Wave Technologies CPT Codes 83891 – Molecular isolation 83892 x8 – Enzymatic digestion 83896 x12 – Nucleic acid probe, each 83903 x4 – Mutation scanning 83908 x4 – Amplification each sequence 83912 – Interpretation and report Turnaround Time 2-3 days Specimen Requirements 5.0 mL (min. 3.0 mL) whole blood EDTA, ACD accepted. Specimen Stability Storage & Handling Causes for Rejection Clotted specimen; Specimen exposed to extreme temperature; Anticoagulant toxic to cells; Insufficient number of cells Reference Range UGT1A1 *28 allele detected/not detected Related Content
Description This test is indicated for patients with metastatic carcinoma of the colon or rectum who are candidates for first-line chemotherapy with CAMPTOSAR® (irinotecan) to assist with the identification of those patients who may be at risk for therapy-related toxicity. References
Trademarks Invader is a registered trademark of Third Wave Technologies, Inc., a wholly owned subsidiary of Hologic, Inc.
Camptosar is a registered trademark of Pfizer. |
Follow MPLNTesting Links
Search Test DirectoryA-Z Test Names
Tests by CategoryFeatured Tests
|